Vinblastine is used in combination with other chemotherapy drugs to treat Hodgkin's lymphoma (Hodgkin's disease) and non-Hodgkin's lymphoma (types of cancer that begin in a type of white blood cell that normally fights infection), and cancer of the testicles. It is also used to treat Langerhans cell histiocytosis (histiocytosis X; Letterer-Siwe disease; a condition in which too many of a certain type of white blood cell grows in parts of the body). It may also be used to treat breast cancer that has not improved after treatment with other medications and gestational trophoblastic tumors (a type of tumor that forms inside a woman's uterus while she is pregnant) that has not improved after surgery or treatment with other medications. Vinblastine is in a class of medications called vinca alkaloids. It works by slowing or stopping the growth of cancer cells in your body.
Related journals of Vinblastine
Cancer Medicine & Anti Cancer Drugs, Journal of Cancer Diagnosis, Journal of Cancer Clinical Trials, Journal of Carcinogenesis & Mutagenesis, Journal of Brain Tumors & Neurooncology, Journal of Carcinogenesis, Oral Oncology, American Journal of Translational Research, Hormones and Cancer, Advances in Biological Regulation, Cancer genetics, Recent Patents on Anti-Cancer Drug Discovery, Cancer Immunity, Melanoma Research.